1. Home
  2. QUIK vs ANIK Comparison

QUIK vs ANIK Comparison

Compare QUIK & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$11.48

Market Cap

196.7M

Sector

Technology

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

SELL

Current Price

$19.07

Market Cap

200.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
QUIK
ANIK
Founded
1988
1983
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.7M
200.9M
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
QUIK
ANIK
Price
$11.48
$19.07
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$23.00
$23.00
AVG Volume (30 Days)
★ 208.5K
66.9K
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 80.16
EPS
N/A
★ N/A
Revenue
$20,112,000.00
★ $112,819,000.00
Revenue This Year
$73.33
$7.82
Revenue Next Year
$16.92
$5.44
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.28
$8.67
52 Week High
$24.33
$22.88

Technical Indicators

Market Signals
Indicator
QUIK
ANIK
Relative Strength Index (RSI) 52.40 37.57
Support Level $10.25 $13.88
Resistance Level $14.81 $22.70
Average True Range (ATR) 0.47 0.65
MACD 0.19 -0.22
Stochastic Oscillator 73.22 4.85

Price Performance

Historical Comparison
QUIK
ANIK

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: